Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03599453 |
|---|---|
| Brief Title: | Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer |
| First Submitted : | July 16, 2018 |
| First Submitted that Met QC Criteria : | July 16, 2018 |
| First Posted : | July 26, 2018 |
| Last Update Submitted that Met QC Criteria : | January 20, 2023 |
| Last Update Posted : | January 23, 2023 |